Open Orphan PLC
OTC:OPORF
Relative Value
There is not enough data to reliably calculate the relative value of OPORF.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
OPORF Competitors Multiples
Open Orphan PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
O
|
Open Orphan PLC
OTC:OPORF
|
67.1m USD | 1.4 | -86.5 | 4.3 | 6.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 368.3 | 4 361 | 1 382.7 | 2 954.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
194.7B USD | 4.4 | 29.2 | 20.3 | 27.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
147.8B USD | 6 | 40.9 | 22.7 | 34.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 14.4 | 49.6 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.5B CHF | 5.6 | 38.6 | 28.5 | 28.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
282.1B CNY | 6.3 | 18.7 | 18.9 | 18.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.6B USD | 4.9 | 25.9 | 19 | 22.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28B USD | 7 | 32.3 | 23.8 | 26.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.8B USD | 1.8 | 21.2 | 11.8 | 17.7 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
162.2B HKD | 7.2 | 34.3 | 24.1 | 24.1 |